Literature DB >> 29742234

Temporal trend and associated factors to advanced stage at diagnosis of cervical cancer: analysis of data from hospital based cancer registries in Brazil, 2000-2012.

Nelson Luiz Renna Junior1, Gulnar Azevedo E Silva1.   

Abstract

OBJECTIVE: To analyze the time trend and analyze the determinants of stage at diagnosis of cervical cancer in Brazil.
METHODS: Time trend analysis and cross-sectional study using data from hospital-based cancer registries (2000-2012); multinomial and joinpoint regression statistical models were used.
RESULTS: 65.843 cases were analyzed; the median interval between diagnosis and treatment was 59 days; the percentage of advanced staging increased, annual percent change 1.10% (95%CI 0.80;1.50); women with higher education (compared to unlettered) had less odds of late stage diagnosis (OR=0.38; 95%CI 0.31;0.47); among indigenous (OR=2.38; 95%CI 1.06;5.33) and black women (OR=1.16; 95%CI 1.02;1.31), compared to white, and in the North region (OR=2.55; 95%CI 2.26;2.89), compared to the Southeast, the odds was higher; other factors positively related to advanced stage were 'age', 'histology', and marital status'. Conclusion Inequities affect the odds of late stage diagnosis of cervical cancer.

Entities:  

Mesh:

Year:  2018        PMID: 29742234     DOI: 10.5123/s1679-49742018000200003

Source DB:  PubMed          Journal:  Epidemiol Serv Saude        ISSN: 1679-4974


  2 in total

1.  Inequalities in Temporal Effects on Cervical Cancer Mortality in States in Different Geographic Regions of Brazil: An Ecological Study.

Authors:  Karina Cardoso Meira; Carinne Magnago; Angelo Braga Mendonça; Stephane Fernanda Soares Duarte; Pedro Henrique Oliveira de Freitas; Juliano Dos Santos; Dyego Leandro Bezerra de Souza; Taynãna César Simões
Journal:  Int J Environ Res Public Health       Date:  2022-05-05       Impact factor: 4.614

2.  The Global Burden of Disease Study Estimates of Brazil's Cervical Cancer Burden.

Authors:  Nathalia V S Reis; Brenda B Andrade; Maximiliano R Guerra; Maria Tereza B Teixeira; Deborah C Malta; Valéria M A Passos
Journal:  Ann Glob Health       Date:  2020-06-09       Impact factor: 2.462

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.